Frédéric Bost
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Epidemiology top 0.5%
- Autophagy in Disease and Therapy
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
-
- Cancer, Hypoxia, and Metabolism 16
-
- Metabolism, Diabetes, and Cancer 24
- PI3K/AKT/mTOR signaling in cancer 10
- Protein Kinase Regulation and GTPase Signaling 7
- Melanoma and MAPK Pathways 7
- Co-authors
- Yannick LE MARCHAND‐BRUSTEL (15 shared papers)Jean‐François Tanti (23 shared papers)Bernard Binétruy (14 shared papers)Issam Ben Sahra (7 shared papers)Kathiane Laurent (14 shared papers)Leslie Caron (10 shared papers)Myriam Aouadi (8 shared papers)Sophie Giorgetti‐Peraldi (7 shared papers)
- Journals
- Journal of Biological Chemistry (6 papers)Oncogene (4 papers)Oncotarget (3 papers)International Journal of Molecular Sciences (3 papers)Diabetes (3 papers)
- Partner nations
- FranceUnited StatesMonaco
In The Last Decade
Frédéric Bost
98 papers receiving 11.0k citations
Frédéric Bost's Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 1.9k
- Epidemiology 3.4k
- Molecular Biology 6.4k
- Physiology 384
- Geriatrics and Gerontology 250
Countries citing papers authored by Frédéric Bost
This map shows the geographic impact of Frédéric Bost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Bost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Bost more than expected).
Fields of papers citing papers by Frédéric Bost
This network shows the impact of papers produced by Frédéric Bost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Bost. The network helps show where Frédéric Bost may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Bost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy Hit paper breakdown → | 2012 | 3543 |
| 2 | The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level Hit paper breakdown → | 2008 | 761 |
| 3 | Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1 Hit paper breakdown → | 2011 | 538 |
| 4 | 2004 | 489 | |
| 5 | 2010 | 461 | |
| 6 | 2010 | 436 | |
| 7 | 2017 | 363 | |
| 8 | 2005 | 286 | |
| 9 | 2008 | 232 | |
| 10 | 1997 | 206 | |
| 11 | 1998 | 193 | |
| 12 | 2002 | 165 | |
| 13 | 2006 | 164 | |
| 14 | 1998 | 159 | |
| 15 | 1997 | 158 | |
| 16 | 2012 | 141 | |
| 17 | 2010 | 139 | |
| 18 | 1999 | 132 | |
| 19 | 2020 | 127 | |
| 20 | 2006 | 125 |
About Frédéric Bost
Frédéric Bost is a scholar working on Cancer Research, Molecular Biology, Oncology, Physiology and Cell Biology, having authored 103 papers that have together received 11.2k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (24 papers), Cancer, Hypoxia, and Metabolism (16 papers), Cancer-related Molecular Pathways (11 papers), Adipose Tissue and Metabolism (11 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Pancreatic function and diabetes (9 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Melanoma and MAPK Pathways (7 papers). The work is most often cited by research in Cancer Research (1.9k citations), Epidemiology (3.4k citations), Molecular Biology (6.4k citations), Physiology (384 citations) and Geriatrics and Gerontology (250 citations). Frédéric Bost has collaborated with scholars based in France, United States and Monaco. Frequent co-authors include Yannick LE MARCHAND‐BRUSTEL, Jean‐François Tanti, Bernard Binétruy, Issam Ben Sahra, Kathiane Laurent, Leslie Caron, Myriam Aouadi, Sophie Giorgetti‐Peraldi, Patrick Auberger and Dan Mercola. Their work appears in journals such as Journal of Biological Chemistry, Oncogene, Oncotarget, International Journal of Molecular Sciences and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.